Home
Progenity

Progenity Market Share Analysis for November 2025

Health > Womens Health

Domainprogenity.com

Year Founded2010

Employees51 - 200

Annual Revenue$1M - $2M

Progenity

Progenity (including company regionals)

progenity.com

See more website traffic and engagement information

Progenity Revenue up to November 2025 is 1M - 2M

revenue generated by Progenity top domains

Progenity top domains revenue over 3 years

Revenue for Progenity top domains

progenity.com1M - 2M

See more with Sales Intelligence

Total visits to Progenity's top domains

Understand Progenity market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Progenity's top domains

Analyze Progenity engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Progenity's top domains

See how Progenity keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Progenity top competitors by domain

Top similar sites in November 2025, ranked by their affinity

panoramatest.comCompany NamePanorama Prenatal TestEmployees51 - 200HQCanada, san carlosAnnual revenue$1M - $2MTotal visits--Health > Womens Health

Top technologies used by Progenity

These are the website technologies, by industry, used by Progenity top domains

Advertising (11)

DoubleClick

Social (4)

Instagram

Widget (4)

Twemoji

Content Management System (3)

WordPress

More Technologies

9

See all

News & Signals from Progenity

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsProgenity, Inc. is developing PGN-600 program.Progenity is developing the PGN-600 program, which consists of oral liquid formulation of tofacitinib delivered to the colon via the DDS capsule, for the treatment of ulcerative colitis.

NewsProgenity, Inc. sold assets to Nwpathology in the amount of $10.9M on Dec 20th '21.Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced it has successfully closed the business divestiture of its affiliate Avero Diagnostics through an asset sale to Northwest Pathology.

NewsProgenity, Inc. launched patent related to single-molecule detection platform on Dec 2nd '21.Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics, today announced a new patent related to its single-molecule detection platform under development.